IMRN
Immuron Limited
NASDAQ · Healthcare · Biotechnology · AU
$1.80
+62.16%Sep 4, 2026, 10:00 UTC
Immuron Limited announced it has executed an exclusive distribution agreement with Calmino group AB to launch PROIBS in the United States, following its earlier launch of PROIBS in Australia during FY2026.